Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations [Yahoo! Finance]
Fulcrum Therapeutics, Inc. (FULC)
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The clinical-stage biopharmaceutical firm posted a loss of $0.25 per share for the quarter, coming in ahead of forecasts calling for a $0.30 per share loss. Net loss totaled $18.9 million for the three months ended March 31, 2026, compared with $17.7 million in the same period a year earlier. Shares gained 2.81% in pre-market activity following the announcement. During the quarter, the company highlighted encouraging clinical findings for pociredir, noting strong induction of fetal hemoglobin along with improvements in key indicators of hemolysis and anemia. Fulcrum said it is targeting the launch of a potential registration-enabling trial in the second half of 2026, subject to feedback from the FDA. “The strength of the clinical data presented in the first quarter further reinforce our conviction in pociredir's potential to address the underlying biology of sickle cell disease,” said Alex C. Sapir, Fulcrum's President and Chief Executive Officer. “With a strong balance sheet ext
Show less
Read more
Impact Snapshot
Event Time:
FULC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FULC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FULC alerts
High impacting Fulcrum Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FULC
News
- Fulcrum Therapeutics Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Fulcrum (FULC) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 [Yahoo! Finance]Yahoo! Finance
- Fulcrum Therapeutics GAAP EPS of -$0.25 beats by $0.05 [Seeking Alpha]Seeking Alpha
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026GlobeNewswire
FULC
Earnings
- 4/27/26 - Beat
FULC
Analyst Actions
- 2/24/26 - Leerink Partners
FULC
Sec Filings
- 4/27/26 - Form 10-Q
- 4/27/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- FULC's page on the SEC website